Intranasal vaccination produces potent systemic immunity against HIV and SARS-CoV-2 in animal models

More than 150 children dead in Zimbabwe measles outbreak
17 August 2022
A step closer to a low toxicity treatment for childhood leukemia
17 August 2022

Intranasal vaccination produces potent systemic immunity against HIV and SARS-CoV-2 in animal models

Even though most viruses cause infection directly through mucosal cells, the vast majority of vaccines are administered intramuscularly in a cellular mismatch that doesn’t always produce optimum immunity.

Comments are closed.